LinksterTX

INTELLECTUAL PROPERTY

exclusive.

Linkster Therapeutics has a broad intellectual property base in the fields of targeted therapeutics, the Sybody® platform, the Flycode® technology, and in the field of target generation. As science leader and innovator, Linkster Therapeutics continues to build strong intellectual property. The worldwide exclusive license to the Flycode® technology makes Linkster Therapeutics the exclusive source of peptide barcode technology for partners.